Loading...

Intellectia LogoIntellectia
Features
Markets
News
Resources
Pricing
  1. Home
  2. Stock
  3. POM
POM logo

POM Overview

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • AI Stock Picker
  • Swing Trading
  • SwingMax Portfolio
  • QuantAI Alpha Pick
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • Financial AI Agent
  • AI Screener
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Loading chart...

High
0.249
Open
0.232
VWAP
0.24
Vol
45.61K
Mkt Cap
29.06M
Low
0.232
Amount
11.03K
EV/EBITDA(TTM)
--
Total Shares
119.19M
EV
350.78M
EV/OCF(TTM)
--
P/S(TTM)
--
PomDoctor Ltd is a holding company principally engaged in operating a online medical services platform for chronic diseases. The Company operates its businesses through two segments. The Internet Hospital segment mainly engaged in providing online follow-up consultations and online prescription renewal service to customers and also sells prescription to customers through the website and apps. The Pharmaceutical Supply Chain segment mainly engaged in pharmacy retail sales and wholesale. The Company mainly operates its businesses in the domestic market.
Show More

Events Timeline

(ET)
2026-02-02
06:10:00
PomDoctor Receives Nasdaq Deficiency Notice
select
2025-12-10 (ET)
2025-12-10
09:40:00
Pepco Holdings, Inc. Trading Resumes
select
2025-12-10
09:40:00
Pepco Holdings Trading Halted Due to Volatility
select
2025-10-08 (ET)
2025-10-08
11:36:22
PomDoctor Debuts at $4.50 After IPO Set at $4.00 per Share
select
2025-10-08
08:03:04
PomDoctor Sets IPO Price at $4.00 for 5 Million Shares
select

News

Globenewswire
7.0
03-04Globenewswire
Pomdoctor Investors Encouraged to Seek Legal Rights Amid Significant Losses
  • Legal Investigation: Faruqi & Faruqi, LLP is investigating potential claims against Pomdoctor Limited and reminds investors to apply by April 13, 2026, to become lead plaintiffs in a federal securities class action to protect their legal rights.
  • Stock Price Plunge: Pomdoctor's share price significantly dropped from approximately $0.50 to about $0.38 between December 10 and 11, 2025, representing a 24% decline in a single trading session, reflecting investor concerns regarding the company's financial performance.
  • False Promotion Allegations: The lawsuit alleges that Pomdoctor and its executives violated federal securities laws through false statements and undisclosed stock manipulation activities, misleading investors about the company's prospects and affecting the stock's fair valuation.
  • Investor Rights Protection: Faruqi & Faruqi encourages anyone with information regarding Pomdoctor's conduct, including whistleblowers and former employees, to contact the firm to provide support and legal assistance for affected investors.
Globenewswire
7.0
03-03Globenewswire
Reminder of Class Action for PomDoctor Securities Purchasers
  • Class Action Notice: Rosen Law Firm reminds investors who purchased PomDoctor Ltd. (NASDAQ: POM) securities between October 9 and December 11, 2025, to apply as lead plaintiffs by April 7, 2026, to participate in the class action and seek compensation.
  • Lawsuit Background: The lawsuit alleges that PomDoctor made false and misleading statements during the class period, failing to disclose a fraudulent stock promotion scheme involving social media, which led to investor losses during inflated price periods.
  • Law Firm Credentials: Rosen Law Firm specializes in securities class actions and has achieved the largest securities class action settlement against a Chinese company, demonstrating its successful track record and extensive experience in this field.
  • Investor Action Recommendations: Investors can visit the Rosen Law Firm website or call the toll-free number for more information, ensuring they select qualified legal counsel to protect their rights in the litigation and avoid inexperienced intermediaries.
PRnewswire
7.0
03-03PRnewswire
PomDoctor Securities Class Action Reminder
  • Class Action Notice: Rosen Law Firm reminds investors who purchased PomDoctor Ltd. (NASDAQ:POM) securities between October 9 and December 11, 2025, to apply as lead plaintiffs by April 7, 2026, to potentially receive compensation through the class action lawsuit.
  • Lawsuit Background: The lawsuit alleges that PomDoctor made false and misleading statements during the class period, involving fraudulent stock promotions and insider trading through offshore accounts, which significantly harmed investors.
  • Law Firm Credentials: Rosen Law Firm specializes in securities class actions and has achieved the largest settlement against a Chinese company, recovering over $438 million for investors in 2019 alone, demonstrating its strong track record in this field.
  • Investor Guidance: Investors are advised to carefully select qualified counsel with proven success, avoiding firms that merely act as intermediaries, to ensure effective legal representation in the litigation process.
Globenewswire
7.0
03-02Globenewswire
PomDoctor Faces Class Action Lawsuit Over Securities Violations
  • Class Action Initiated: Bronstein, Gewirtz & Grossman, LLC has announced a class action lawsuit against PomDoctor, seeking damages for investors who purchased securities between October 9 and December 11, 2025, indicating strong investor concern over potential fraud.
  • False Statement Allegations: The complaint alleges that PomDoctor failed to disclose significant adverse facts regarding its business and trading activities during the class period, misleading investors and affecting their assessment of the company's prospects.
  • Insider Trading Issues: The lawsuit mentions that insiders used offshore accounts to facilitate stock dumping amid a fraudulent promotion scheme involving social media misinformation, highlighting serious governance failures within the company.
  • Investor Rights Protection: Investors have until April 6, 2026, to request lead plaintiff status, with Bronstein, Gewirtz & Grossman, LLC offering contingency fee representation, emphasizing the importance of protecting investor rights and the need for legal support.
Globenewswire
7.0
03-01Globenewswire
PomDoctor Securities Class Action Reminder
  • Class Action Notice: Rosen Law Firm reminds investors who purchased PomDoctor Ltd. (NASDAQ: POM) securities between October 9 and December 11, 2025, to apply as lead plaintiffs by April 7, 2026, to protect their rights in the ongoing class action lawsuit.
  • Fee Arrangement: Investors participating in the class action will incur no out-of-pocket costs, as the law firm operates on a contingency fee basis, which alleviates financial burdens and encourages more affected investors to join the lawsuit.
  • Lawsuit Background: The lawsuit alleges that PomDoctor made false and misleading statements during the class period, involving fraudulent stock promotions and insider trading through offshore accounts, resulting in significant investor losses and highlighting serious governance and transparency issues within the company.
  • Law Firm's Strength: Rosen Law Firm is renowned for its successful track record in securities class actions, having achieved the largest settlement against a Chinese company and recovering hundreds of millions for investors, demonstrating its expertise and resource advantages in handling such cases.
PRnewswire
7.0
02-27PRnewswire
Investigation Launched into Pomdoctor Securities Litigation
  • Legal Investigation: Faruq & Faruqi LLP is investigating Pomdoctor Limited for potential securities litigation due to allegations of false and misleading statements made between October and December 2025, which may have caused investor losses.
  • Stock Price Plunge: Pomdoctor's share price fell from approximately $0.50 on December 10, 2025, to about $0.38 on December 11, representing a 24% decline in a single trading session, reflecting market concerns over its financial performance.
  • Class Action Deadline: Investors must apply by April 6, 2026, to serve as lead plaintiffs in the federal securities class action lawsuit, allowing them to represent other affected investors in the litigation.
  • Disclosure Failures: The lawsuit alleges that Pomdoctor failed to disclose false information and insider trading related to stock price manipulation, leading to investor misconceptions about the company's prospects, which could impact its future legal liabilities.

Valuation Metrics

The current forward P/E ratio for PomDoctor Ltd (POM.O) is 0.00, compared to its 5-year average forward P/E of 0.00. For a more detailed relative valuation and DCF analysis to assess PomDoctor Ltd's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PE
0.00
Current PE
0.00
Overvalued PE
0.00
Undervalued PE
0.00

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average EV/EBITDA
0.00
Current EV/EBITDA
0.00
Overvalued EV/EBITDA
0.00
Undervalued EV/EBITDA
0.00

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PS
0.00
Current PS
0.00
Overvalued PS
0.00
Undervalued PS
0.00

Financials

AI Analysis
Annual
Quarterly

Related Community Screener

stocks under $1 that will be bullish today
Intellectia · 96 candidates
Price: <= $1.00
Ticker
Name
Market Cap$
top bottom
SXTC logo
SXTC
China SXT Pharmaceuticals Inc
11.70M
SAFX logo
SAFX
XCF Global Inc
28.75M
MKDW logo
MKDW
MKDWELL Tech Inc
14.59M
SRXH logo
SRXH
Srx Health Solutions Inc
11.89M
ADIL logo
ADIL
Adial Pharmaceuticals Inc
6.04M
GRI logo
GRI
GRI Bio Inc
2.26M
stocks under $0.50 with an rsi under 20
Intellectia · 33 candidates
Price: <= $0.50Rsi Category: oversold
Ticker
Name
Market Cap$
top bottom
MTEN logo
MTEN
Mingteng International Corp Inc
5.55M
ATPC logo
ATPC
Agape ATP Corp
4.10M
SXTC logo
SXTC
China SXT Pharmaceuticals Inc
11.70M
CCTG logo
CCTG
CCSC Technology International Holdings Ltd
3.84M
APLT logo
APLT
Applied Therapeutics Inc
14.63M
ZJYL logo
ZJYL
Jin Medical International Ltd
19.82M
stocks under $1 with an rsi under 20
Intellectia · 53 candidates
Price: <= $1.00Rsi Category: oversold
Ticker
Name
Market Cap$
top bottom
AIIO logo
AIIO
Robo.ai Inc
89.22M
PSTV logo
PSTV
Plus Therapeutics Inc
52.05M
HURA logo
HURA
TuHURA Biosciences Inc
41.71M
XLO logo
XLO
Xilio Therapeutics Inc
40.33M
POM logo
POM
PomDoctor Ltd
35.21M
OTLK logo
OTLK
Outlook Therapeutics Inc
32.44M
stocks under $1 with an rsi under 10
Intellectia · 53 candidates
Price: <= $1.00Rsi Category: oversold
Ticker
Name
Market Cap$
top bottom
AIIO logo
AIIO
Robo.ai Inc
89.22M
PSTV logo
PSTV
Plus Therapeutics Inc
52.05M
HURA logo
HURA
TuHURA Biosciences Inc
41.71M
XLO logo
XLO
Xilio Therapeutics Inc
40.33M
POM logo
POM
PomDoctor Ltd
35.21M
OTLK logo
OTLK
Outlook Therapeutics Inc
32.44M
stocks under $1 with an rsi under 15
Intellectia · 53 candidates
Price: <= $1.00Rsi Category: oversold
Ticker
Name
Market Cap$
top bottom
MTEN logo
MTEN
Mingteng International Corp Inc
5.55M
ATPC logo
ATPC
Agape ATP Corp
4.10M
SXTC logo
SXTC
China SXT Pharmaceuticals Inc
11.70M
CCTG logo
CCTG
CCSC Technology International Holdings Ltd
3.84M
APLT logo
APLT
Applied Therapeutics Inc
14.63M
ZJYL logo
ZJYL
Jin Medical International Ltd
19.82M
stovks to buy on wed from 20 to 40 cents
Intellectia · 81 candidates
Price: $0.20 - $0.40
Ticker
Name
Market Cap$
top bottom
SGMO logo
SGMO
Sangamo Therapeutics Inc
127.97M
IXHL logo
IXHL
Incannex Healthcare Inc
123.43M
GPUS logo
GPUS
Hyperscale Data Inc
96.48M
AURE logo
AURE
Aurelion Inc
95.26M
AIIO logo
AIIO
Robo.ai Inc
89.22M
ZONE logo
ZONE
CleanCore Solutions Inc
79.36M

Whales Holding POM

Trading Trends

    Insider
    Hedge Fund
    Congress Trading

People Also Watch

Frequently Asked Questions

What is PomDoctor Ltd (POM) stock price today?

The current price of POM is 0.2438 USD — it has decreased -0.41

What is PomDoctor Ltd (POM)'s business?

PomDoctor Ltd is a holding company principally engaged in operating a online medical services platform for chronic diseases. The Company operates its businesses through two segments. The Internet Hospital segment mainly engaged in providing online follow-up consultations and online prescription renewal service to customers and also sells prescription to customers through the website and apps. The Pharmaceutical Supply Chain segment mainly engaged in pharmacy retail sales and wholesale. The Company mainly operates its businesses in the domestic market.

What is the price predicton of POM Stock?

Wall Street analysts forecast POM stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for POM is USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is PomDoctor Ltd (POM)'s revenue for the last quarter?

PomDoctor Ltd revenue for the last quarter amounts to 16.23 USD, increased 0.12

What is PomDoctor Ltd (POM)'s earnings per share (EPS) for the last quarter?

PomDoctor Ltd. EPS for the last quarter amounts to USD, decreased

How many employees does PomDoctor Ltd (POM). have?

PomDoctor Ltd (POM) has 156 emplpoyees as of March 05 2026.

What is PomDoctor Ltd (POM) market cap?

Today POM has the market capitalization of 29.06M USD.